Harms and benefits of adoptive immunotherapy for postoperative hepatocellular carcinoma: an updated review

The harms and benefits of adoptive immunotherapy (AIT) for patients with postoperative hepatocellular carcinoma (HCC) are controversial among studies. This study aims to update the current evidence on efficacy and safety of AIT for patients with HCC who have received curative therapy. Electronic dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Bao-Hong, Li, Ru-Hong, Yuan, Wei-Ping, Yang, Tian, Tong, Tie-Jun, Peng, Ning-Fu, Li, Le-Qun, Zhong, Jian-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392348/
https://www.ncbi.nlm.nih.gov/pubmed/28061472
http://dx.doi.org/10.18632/oncotarget.14507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392348/
https://www.ncbi.nlm.nih.gov/pubmed/28061472
http://dx.doi.org/10.18632/oncotarget.14507

Ejemplares similares